• ASCOT Trial on testing CRP for cardiovascular outcomes
• DEFINE Trial on CETP inhibition with anacetrapib
• ASSERT Study on an oral agent inducing ApoA-1 synthesis
• SIMPLICITY HTN-2 Study on renal sympathetic denervation for hypertension

• Donald Lloyd-Jones, MD, ScM, FACC, FAHA - Chair of Preventive Medicine, Northwestern University Feinberg School of Medicine
• Christopher P. Cannon, MD - Associate Professor of Medicine, Harvard Medical School
• Eliot A. Brinton, MD, FAHA - Director of the Metabolism Section of Cardiovascular Genetics, University of Utah School of Medicine
• Murray Esler, MD - Associate Professor, Baker Heart Research Institute
• Margaret Fang, MD, MPH - Medical Director, UCSF Anticoagulation Clinic
• John A. Ryan, MD, FACS - Cardiology Fellow, University of Chicago Hospitals

You are subscribed to ModernMedicine. To unsubscribe, click here

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.